Article | September 2, 2025

Bioequivalence In Topical Generics: Regulatory Considerations Around Bioequivalence In Topical Generic Drug Product Development

By Charles Evans, SVP of Pharmaceutical Development, MedPharm, Marc Brown, MedPharm Co-founder now MLBT Investments, and Jon Lenn, Chief Scientific Officer, MedPharm

iStock-1074507482-topical-skincare-skin-

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Water Online? Subscribe today.

Subscribe to Water Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Water Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

MedPharm